Additionally, Aclarion disclosed that during a special stockholders’ meeting on September 23, 2024, the board of directors was granted the authority to implement a reverse stock split within a ...

BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company ...

This patent broadens Aclarion’s proprietary rights beyond previous limitations. Aclarion has also announced a reverse stock split at a 1-for-335 ratio, effective January 29, 2025, to maintain ...

Additionally, Aclarion disclosed that during a special stockholders’ meeting on September 23, 2024, the board of directors was granted the authority to implement a reverse stock split within a range ...